All engagements
Scientific Due Diligence
Rapid PhD-level scientific assessment for biotech investment decisions — technology feasibility, IP strength, and key risk factors in days, not weeks.
From $3,50048–72 hour turnaroundWritten by the scientist
Request a proposalWhat you get
7 items- 01Technology feasibility assessment (does the science hold up?)
- 02IP portfolio strength evaluation
- 03Competitive positioning in the patent literature
- 04Key risk identification (scientific, regulatory, IP)
- 05Publication and citation analysis
- 06Team capability assessment
- 07Executive summary + detailed technical report
Who this is for
- Venture capital firms evaluating biotech investments
- Family offices and angel investors in life sciences
- Corporate development teams assessing acquisition targets
- Strategic partners evaluating licensing deals
Scope & fee
48 hours to 4 weeks depending on scopeRapid Assessment$3,500
48–72 hours, 5–10 page report
Standard DD$7,500
1–2 weeks, 20–30 page report
Comprehensive DD$15,000+
2–4 weeks, 40+ page report
Next step
Send the specifics. Get a scope back in 24 hours.
A one-paragraph summary of the technology, company, or patent is enough to start.
Request a proposal